As of March 2024 Medpace has a market cap of $12.40 Billion. This makes Medpace the world's 1384th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $12.40 B | 31.89% |
2023 | $9.40 B | 42.38% |
2022 | $6.60 B | -15.54% |
2021 | $7.82 B | 57.08% |
2020 | $4.97 B | 64.25% |
2019 | $3.03 B | 60.59% |
2018 | $1.88 B | 46.95% |
2017 | $1.28 B | -12.53% |
2016 | $1.46 B |
On Mar 27th, 2024 the market cap of Medpace was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | $0.90 B | -92.69% | ๐บ๐ธ USA |